Fact CheckerSign in

NCT04066959Completed

Improving Diabetes in Emerging Adulthood

Improving Diabetes Health in Emerging Adulthood Through an Autonomy Supportive Intervention

Source: ClinicalTrials.gov · Last updated 5 May 2026

Brief summary (registry, in English)

This project will test the efficacy of a multi-component behavioral intervention to improve metabolic control among older adolescents and emerging adults (16-21) with T1D, a group with chronic poor metabolic control. This intervention is grounded in self-determination theory which states that a youth who believes their diabetes management is self-directed, competent, and supported by others is more likely to consistently complete their diabetes self-care. This theory-driven intervention will be scalable to a variety of chronic illness contexts and the knowledge gained from this research will inform self-determination theory and different interventions targeting this population (currently there are no interventions that directly target emerging adults).

Status (registry)
Completed
Study type
Interventional
Enrollment
113 (actual)
First submitted
24 Jul 2019
Start date
16 Nov 2020
Primary completion date
13 Jan 2025
Lead sponsor
Wayne State University
NCT number
NCT04066959

What you commit to

  • Study type: Interventional
  • Participants enrolled: 113
  • From 16 Nov 2020 to the primary completion date, 13 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion:
  • Age 16 years, 0 months - 25 years, 11 months
  • Type 1 diabetes (T1D)
  • HbA1c ≥7.5% currently and averaged over the previous 6 months
  • Duration of diabetes ≥6 months
  • English fluency, both verbal and written
  • Cell phone access with texting capability
    • Exclusion:
  • Psychosis (e.g., schizophrenia or bipolar disorder)
  • Suicidal
  • Developmental delay (moderate or severe mental retardation, or autism) or reading level below sixth grade
  • The presence of another physical health condition that results in atypical diabetes management (e.g., cystic fibrosis)

Age in the registry: 16 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Detroit Medical Center
Coordinator of this site? Confirm its status
DetroitUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.